WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) 2000 LIFEVEST
Zoll Manufacturing Corporation · Decision date Dec 18, 2001
What did the FDA approve?
The FDA database entry for P010030 records an original PMA approval on December 18, 2001, for the WCD 2000 LifeVest system from Zoll Manufacturing Corporation. The approval statement describes the device as indicated for adult patients at risk for sudden cardiac arrest who either are not candidates for or refuse an implantable defibrillator.
The entry lists no supplement type or supplement reason, so no later modification to the original approval is identified in these fields. The statement reports the indicated patient population as stated in the approval record; it does not by itself provide independent evidence of safety or clinical effectiveness.
FDA approval order statement
APPROVAL FOR THE WCD 2000 SYSTEM. THIS DEVICE IS INDICATED FOR ADULT PATIENTS WHO ARE AT RISK FOR SUDDEN CARDIAC ARREST AND EITHER ARE NOT CANDIDATES FOR OR REFUSE AN IMPLANTABLE DEFIBRILLATOR.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 18, 2001
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P010030
- Regulatory pathway
- Premarket approval application
- Applicant
- Zoll Manufacturing Corporation
- Product code
- MVK
- Decision code
- APPR
- Decision date
- Dec 18, 2001
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wearable automated external defibrillator.
- Applicant
- Zoll Manufacturing Corporation
- Product code
- MVK
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P010030 received
Application receipt date recorded by FDA.
P010030 · FDA decision
APPR
P010030/S201 · Related supplement
LifeVest Wearable Defibrillator
P010030/S203 · Related supplement
LifeVest Wearable Defibrillator
P010030/S204 · Related supplement
LifeVest Wearable Defibrillator
P010030/S205 · Related supplement
LifeVest Wearable Defibrillator
Timeline entries are records held by MedtechLedger for P010030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P010030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LifeVest Wearable DefibrillatorP010030/S201 | Zoll Manufacturing Corporation | PMA supplement | Sep 9, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S203 | Zoll Manufacturing Corporation | PMA supplement | Sep 29, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S204 | Zoll Manufacturing Corporation | PMA supplement | Oct 5, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S205 | Zoll Manufacturing Corporation | PMA supplement | Oct 6, 2026 | FDA |
Explore the linked device profile
Other records with product code MVK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Kestra Medical Technologies, Inc. | PMA supplement | Nov 4, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Sep 28, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA approval | Jul 27, 2021 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zoll Manufacturing Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 121 Gamma Dr., Pittsburgh, PA, 15238
Sources and methodology
- Original FDA record: P010030
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



